Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
9.15M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
1.88M
-
Shares change
-
-4.14K
-
Total reported value, excl. options
-
$2.49M
-
Value change
-
+$8.02K
-
Number of buys
-
12
-
Number of sells
-
-7
-
Price
-
$1.20
Significant Holders of AYTU BIOPHARMA, INC - Common Stock (AYTU) as of Q1 2025
34 filings reported holding AYTU - AYTU BIOPHARMA, INC - Common Stock as of Q1 2025.
AYTU BIOPHARMA, INC - Common Stock (AYTU) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.88M shares
of 9.15M outstanding shares and own 20.5% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (1.09M shares), Stonepine Capital Management, LLC (464K shares), RENAISSANCE TECHNOLOGIES LLC (76.8K shares), ARMISTICE CAPITAL, LLC (57.6K shares), GEODE CAPITAL MANAGEMENT, LLC (53.9K shares), CITADEL ADVISORS LLC (30.5K shares), VANGUARD GROUP INC (27.9K shares), BlackRock, Inc. (22.8K shares), Jaffetilchin Investment Partners, LLC (17.4K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (14.9K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.